Next Article in Journal
Development of Gastroretentive Floating Combination Tablets Containing Amoxicillin Trihydrate 500 mg and Levofloxacin 125 mg for Eradicating Resistant Helicobacter pylori
Next Article in Special Issue
Establishing a Relationship between In Vitro Potency in Cell-Based Assays and Clinical Efficacious Concentrations for Approved GLP-1 Receptor Agonists
Previous Article in Journal
Review on Photoacoustic Monitoring after Drug Delivery: From Label-Free Biomarkers to Pharmacokinetics Agents
Previous Article in Special Issue
Analysis of Lipophilicity and Pharmacokinetic Parameters of Dipyridothiazine Dimers with Anticancer Potency
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(10), 1241; https://doi.org/10.3390/pharmaceutics16101241
Action Date Notes Link
article xml file uploaded 24 September 2024 13:01 CEST Original file -
article xml uploaded. 24 September 2024 13:01 CEST Update https://www.mdpi.com/1999-4923/16/10/1241/xml
article pdf uploaded. 24 September 2024 13:01 CEST Version of Record https://www.mdpi.com/1999-4923/16/10/1241/pdf
article supplementary file uploaded. 24 September 2024 13:01 CEST - https://www.mdpi.com/1999-4923/16/10/1241#supplementary
article html file updated 24 September 2024 13:04 CEST Original file https://www.mdpi.com/1999-4923/16/10/1241/html
Back to TopTop